86. Pulmonary arterial hypertension Clinical trials / Disease details
Clinical trials : 1,181 / Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02746237 (ClinicalTrials.gov) | November 2015 | 18/3/2016 | Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585 | A Randomized, Double-blind, Placebo-controlled, Phase 1, First-in-human, Single-center, Safety, Tolerability, Ventricular Repolarization and Pharmacokinetic Study of Single and Multiple Ascending Doses of KAR5585 in Healthy Subjects | Pulmonary Arterial Hypertension | Drug: KAR5585 Capsules;Drug: Placebo Capsules | Karos Pharmaceuticals | NULL | Completed | 18 Years | 65 Years | Both | 120 | Phase 1 | United States |